Structural and molecular conservation of glucagon-like Peptide-1 and its receptor confers selective ligand-receptor interaction
Glucagon-like peptide-1 (GLP-1) is a major player in the regulation of glucose homeostasis. It acts on pancreatic beta cells to stimulate insulin secretion and on the brain to inhibit appetite. Thus, it may be a promising therapeutic agent for the treatment of type 2 diabetes mellitus and obesity. D...
Saved in:
Published in | Frontiers in endocrinology (Lausanne) Vol. 3; p. 141 |
---|---|
Main Authors | , , , , , , |
Format | Journal Article |
Language | English |
Published |
Switzerland
Frontiers Media S.A
2012
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Glucagon-like peptide-1 (GLP-1) is a major player in the regulation of glucose homeostasis. It acts on pancreatic beta cells to stimulate insulin secretion and on the brain to inhibit appetite. Thus, it may be a promising therapeutic agent for the treatment of type 2 diabetes mellitus and obesity. Despite the physiological and clinical importance of GLP-1, molecular interaction with the GLP-1 receptor (GLP1R) is not well understood. Particularly, the specific amino acid residues within the transmembrane helices and extracellular loops of the receptor that may confer ligand-induced receptor activation have been poorly investigated. Amino acid sequence comparisons of GLP-1 and GLP1R with their orthologs and paralogs in vertebrates, combined with biochemical approaches, are useful to determine which amino acid residues in the peptide and the receptor confer selective ligand-receptor interaction. This article reviews how the molecular evolution of GLP-1 and GLP1R contributes to the selective interaction between this ligand-receptor pair, providing critical clues for the development of potent agonists for the treatment of diabetes mellitus and obesity. |
---|---|
Bibliography: | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Reviewed by: Joao Carlos Dos Reis Cardoso, University of Algarve, Portugal; Charlier Dominique Thierry, University of Liege, Belgium Edited by: Billy K. Chow, University of Hong Kong, China This article was submitted to Frontiers in Neuroendocrine Science, a specialty of Frontiers in Endocrinology. |
ISSN: | 1664-2392 1664-2392 |
DOI: | 10.3389/fendo.2012.00141 |